, 14:478
Date: 23 Feb 2014

Systematic Reviews to Ascertain the Safety of Diabetes Medications

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access


Clinicians and patients with type 2 diabetes enjoy an expanding list of medications to improve glycemic control. With this expansion has come a flurry of concerns about the safety of these antihyperglycemic agents, concerns that affect judgments about the risk/benefit balance of therapy. Some of these safety signals have been identified through the synthesis of existing research evidence. Thus, it has become important for clinicians and clinical policymakers to understand the strengths and limitations of systematic reviews and meta-analyses in determining the safety of diabetes medications. In this paper, we highlight key safety concerns with diabetes medications and discuss the role evidence synthesis plays in each, with special attention to its strengths and limitations.
This article is part of the Topical Collection on Pharmacologic Treatment of Type 2 Diabetes